This page is dedicated to the Idiopathic Hypersomnia and Narcolepsy research study, one of over 60 studies supported by the Boston Children’s Rare Disease Collaborative (CRDC). For more information about the CRDC, please visit our home page. Established in 2018, the CRDC supports pediatric rare disease research and provides families with genetic diagnoses that enable personalized treatments, including precision medicine and targeted therapies.
Kiran Maski, MD, MPH
Associate Professor, Harvard Medical School
Attending Physician, Department of Neurology
The Idiopathic Hypersomnia and Narcolepsy research study was established in 2025 and is led by Dr. Kiran Maski.